Skip to main content
Clinical Trials/NCT05826392
NCT05826392
Completed
Not Applicable

A Single-Session Intervention for Adolescents and Young Adults with Internalizing Problems

Baylor College of Medicine1 site in 1 country41 target enrollmentMay 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
Baylor College of Medicine
Enrollment
41
Locations
1
Primary Endpoint
Change in PROMIS (Patient-Reported Outcomes Measurement Information System) Anxiety - Child
Status
Completed
Last Updated
last year

Overview

Brief Summary

With the increasing number of adolescents and young adults (AYA) experiencing depression and anxiety, paired with the lack of time, access, and funding towards social services, AYA need a mental health intervention that is affordable and easily accessible. A single-session intervention (SSI), Project Personality, was developed to improve youth growth mindset and reduce symptoms of internalizing problems, such as anxiety and depression. The purpose of this pilot study is to determine the feasibility of an SSI in adolescents and young adults at a reproductive community health center.

Detailed Description

The mental health of adolescents and young adults (AYA) has greatly been impacted since the beginning of the pandemic. With the increasing number of AYA experiencing depression and anxiety, paired with the lack of time, access, and funding towards social services, AYA need a mental health intervention that is affordable and easily accessible. A single-session intervention (SSI) focused on cultivating an AYA's growth mindset has potential to overcome common barriers to care, such as cost, transportation and stigma related to psychological treatment. Furthermore, research shows having a fixed mindset correlate and can predict higher depressive and anxiety symptoms. Teaching adolescents about growth mindsets could decrease the risk of internalizing symptoms. The SSI, Project Personality, was developed to improve youth growth mindset and reduce symptoms of internalizing problems, such as anxiety and depression. The purpose of this pilot study is to determine the feasibility of an SSI in adolescents and young adults at a reproductive community health center.

Registry
clinicaltrials.gov
Start Date
May 1, 2023
End Date
August 13, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric A Storch

Professor

Baylor College of Medicine

Eligibility Criteria

Inclusion Criteria

  • The adolescent or young adult is between the ages of 13 and
  • The adolescent or young adult has a score above 5 on either PHQ-9 (Patient Health Questionnaire-9) or GAD-7(General Anxiety Disorder-7).
  • The adolescent and their parent participating in the study, or the young adult can read and comprehend English.

Exclusion Criteria

  • The adolescent or the young adult has severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention as defined by the ASQ (Ask Suicide-Screening Questions).
  • The adolescent and their parent participating in the study, or the young adult cannot read or comprehend English.
  • The adolescent and their parent participating in the study, or the young adult cannot travel to the Baylor College of Medicine (BCM) Teen Health Clinic to receive the single-session intervention.

Outcomes

Primary Outcomes

Change in PROMIS (Patient-Reported Outcomes Measurement Information System) Anxiety - Child

Time Frame: Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up

Assesses self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal. 7 items are scored with a total score between 8-40.

Change in Short Mood and Feelings Questionnaire-Adult (SMFQ-A)

Time Frame: Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up

The short version of the self-reported questionnaire that measures depressive symptoms in adults throughout the past 2 weeks. 13 items are scored on a 0-2 scale (0= Not True; 2= True), with a total score between 0-26.

Change in PROMIS (Patient-Reported Outcomes Measurement Information System) Anxiety - Adult

Time Frame: Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up

Assesses self-reported fear, anxious misery, hyperarousal, and somatic symptoms related to arousal in adults. 8 items are scored with a total score between 8-40.

Change in Short Mood and Feelings Questionnaire-Child (SMFQ-C)

Time Frame: Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up

The short version of the self-reported questionnaire that measures depressive symptoms in adolescents 12-17 years old throughout the past 2 weeks. 13 items are scored on a 0-2 scale (0= Not True; 2= True), with a total score between 0-26.

Secondary Outcomes

  • Perceived Secondary Control Scale(Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up)
  • Avoidance and Fusion Questionnaire for Youth-8 (AFQ-8)(Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up)
  • Perceived Primary Control Scale(Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up)
  • The Acceptance and Action Questionnaire-II (AAQ-II)(Baseline (before treatment); 2 weeks post-treatment; 2 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials